• Sphingosine-1-phosphate: Applied Workflows in Cell Survival

  2026-07-30

  Harness Sphingosine-1-phosphate (S1P) for precision modulation of cell proliferation, apoptosis, and vascular maturation in advanced research models. This guide delivers stepwise protocol enhancements, troubleshooting strategies, and insight into the latest mechanistic breakthroughs, anchored by APExBIO’s rigorously validated S1P and the newest reference data on apoptosis signaling.

• Bromodomain Inhibitor, (+)-JQ1: Applied Workflows & Optimiza

  2026-07-30

  Bromodomain Inhibitor, (+)-JQ1 unlocks precise BET bromodomain targeting for apoptosis, inflammation modulation, and emerging non-hormonal male contraception applications. This guide distills the latest experimental workflows, troubleshooting strategies, and translational insights to maximize impact across cancer, stem cell, and immunology research.

• SIRT1/2 Inhibitor IV (cambinol): Translational Research Work

  2026-07-29

  SIRT1/2 Inhibitor IV (cambinol) empowers bench scientists to dissect SIRT1- and SIRT2-regulated processes in cancer and CNS injury. This guide details experimental workflows, optimization strategies, and troubleshooting tips, with a special focus on astrocyte polarization, tumor models, and advanced acetylation assays.

• Cy3 TSA Fluorescence System Kit: Pushing Sensitivity in IHC

  2026-07-29

  The Cy3 TSA Fluorescence System Kit empowers researchers to visualize low-abundance biomolecules with unprecedented clarity in immunohistochemistry, immunocytochemistry, and in situ hybridization. Leverage advanced tyramide signal amplification to unlock new levels of sensitivity for protein and nucleic acid detection, as demonstrated in translational cancer research.

• Galectin-1 Suppresses Hepatic Autophagy via FIP200 in NAFLD

  2026-07-28

  This study uncovers galectin-1 as a direct suppressor of hepatic autophagy through its interaction with the scaffold protein FIP200, elucidating a novel molecular mechanism underlying the progression of non-alcoholic fatty liver disease (NAFLD). The findings reveal a specific interface mediating Gal-1’s inhibitory effect and suggest new intervention points for metabolic liver diseases.

• Reliable Cellular Metabolism Insights with WST-8 Glucose Upt

  2026-07-28

  This article delivers scenario-driven guidance for biomedical researchers using the WST-8 Glucose Uptake Assay Kit (SKU K2303), highlighting reproducible, quantitative solutions for glucose uptake analysis in metabolic research. Practical Q&A blocks address assay principle, protocol optimization, comparative interpretation, and vendor reliability, ensuring evidence-based decisions for diabetes, cancer, and cellular metabolism studies.

• Clodronate Liposomes: Optimizing In Vivo Macrophage Depletio

  2026-07-27

  Clodronate Liposomes enable precise, tissue-specific macrophage depletion for advanced in vivo research, unlocking functional analyses of immune cell roles in aging, infection, and immunotherapy. This guide translates recent breakthroughs into actionable protocols, troubleshooting strategies, and comparative insights to help biomedical scientists achieve reproducible, interpretable outcomes.

• Cy3 TSA Fluorescence System Kit: Spatial Proteome Profiling

  2026-07-27

  Explore how the Cy3 TSA Fluorescence System Kit transforms spatial proteome profiling by enabling ultrasensitive detection of low-abundance biomolecules. This in-depth analysis reveals practical innovations for immunohistochemistry and single-cell-type resolution studies.

• Galectin-1–FIP200 Axis Impairs Autophagy in Hepatic Steatosi

  2026-07-26

  This study reveals that Galectin-1 directly inhibits hepatic autophagy by binding to the scaffold protein FIP200, thereby exacerbating steatosis and metabolic dysfunction in NAFLD models. These findings uncover a novel mechanistic link between Gal-1 overexpression and impaired metabolic adaptation, providing new targets for investigating metabolic liver disease.

• HATU in Peptide Synthesis Chemistry: Protocols and Precision

  2026-07-25

  HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) accelerates amide bond formation with exceptional efficiency, enabling high-yield peptide synthesis and complex inhibitor construction. This article delivers practical workflow enhancements, troubleshooting strategies, and insights from landmark IRAP inhibitor studies to unlock the full translational power of HATU for modern research.

• LY2886721: BACE Inhibitor Workflows for Amyloid Beta Reducti

  2026-07-24

  LY2886721 stands out as a potent, oral BACE inhibitor tailored for translational Alzheimer’s disease research. This article delivers actionable protocols, troubleshooting insights, and a critical appraisal of the latest synaptic safety evidence, empowering researchers to achieve reliable amyloid beta reduction using APExBIO’s benchmark compound.

• Arrb2-Mediated M2 Macrophage Polarization Mitigates Hepatic

  2026-07-24

  The reference study reveals that hepatocyte-specific upregulation of Arrb2 promotes M2 macrophage polarization, attenuating hepatic ischemia–reperfusion injury (IRI) via increased production of the metabolite 6-ketoLCA. These findings illuminate critical hepatocyte–macrophage interactions and suggest new molecular targets for improving liver transplantation outcomes.

• Exosomal SNORD52 Drives M2 Macrophage Polarization via JAK2/

  2026-07-23

  This study reveals that exosomal SNORD52, released by hepatoma cells, promotes M2 macrophage polarization through activation of the JAK2/STAT6 pathway. These findings provide new mechanistic insights into tumor-immune microenvironment modulation in hepatocellular carcinoma and highlight potential avenues for targeted intervention.

• Radioiodinated Balsalazide: Selective Imaging of Ulcerative

  2026-07-23

  This study introduces a highly selective radioiodinated balsalazide tracer for noninvasive imaging of ulcerative colitis in mice, achieving high radiochemical purity and sustained colon uptake. The innovation addresses limitations of prior radiotracers, enabling more reliable tracking of disease localization and progression for preclinical inflammatory bowel disease research.

• iRhom2 Regulates Olfactory Receptor Expression and Adaptatio

  2026-07-22

  This study uncovers a specialized role for iRhom2 in olfactory sensory neurons, revealing how it modulates olfactory receptor gene expression and participates in activity-dependent adaptation. These findings refine our understanding of sensory regulation and suggest new molecular targets for dissecting olfactory signaling.

15166 records 1/1012 page Next 12345 下5页 Last page